skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 11,861  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Tiny Lab Sees Profit Potential in SARS Test
Material Type:
Newspaper Article
Add to My Research

Tiny Lab Sees Profit Potential in SARS Test

The Wall Street journal. Eastern edition, 2003-06-10

Copyright Dow Jones & Company Inc Jun 10, 2003 ;ISSN: 0099-9660 ;EISSN: 2574-9579

Digital Resources/Online E-Resources

2
Interferons May Be First to Reach Trials for SARS
Material Type:
Newspaper Article
Add to My Research

Interferons May Be First to Reach Trials for SARS

The Wall Street journal. Eastern edition, 2003-09-16

Copyright (c) 2003, Dow Jones & Company, Inc. ;ISSN: 0099-9660 ;EISSN: 2574-9579

Digital Resources/Online E-Resources

3
Search Continues for SARS Drugs; Compounds Are Studied In the Test Tube for Now; Stricter Human Tests Loom
Material Type:
Newspaper Article
Add to My Research

Search Continues for SARS Drugs; Compounds Are Studied In the Test Tube for Now; Stricter Human Tests Loom

The Wall Street journal. Eastern edition, 2003-09-17

Copyright (c) 2003, Dow Jones & Company, Inc. ;ISSN: 0099-9660 ;EISSN: 2574-9579

Digital Resources/Online E-Resources

4
Progress Reported in SARS Vaccine Effort
Material Type:
Newspaper Article
Add to My Research

Progress Reported in SARS Vaccine Effort

The New York times, 2003-11-09

Copyright New York Times Company Nov 9, 2003 ;ISSN: 0362-4331 ;CODEN: NYTIAO

Digital Resources/Online E-Resources

5
Progress Reported in SARS Vaccine Effort
Material Type:
Newspaper Article
Add to My Research

Progress Reported in SARS Vaccine Effort

New York Times (Online), 2003-11-09

Copyright 2019 The New York Times Company ;EISSN: 1553-8095

Full text available

6
Jiji Press Roundup of Recent Bio News 1
Material Type:
Newsletter Article
Add to My Research

Jiji Press Roundup of Recent Bio News 1

Jiji Press English News Service, 2003, p.1

Copyright JIJI Press America, Ltd. Jul 25, 2003 ;Copyright JIJI Press America, Ltd. Oct 3, 2003 ;Copyright JIJI Press America, Ltd. Jul 1, 2003 ;Copyright JIJI Press America, Ltd. Dec 1, 2003 ;Copyright JIJI Press America, Ltd. Sep 8, 2003 ;Copyright JIJI Press America, Ltd. May 19, 2003 ;Copyright JIJI Press America, Ltd. Feb 17, 2003 ;Copyright JIJI Press America, Ltd. May 13, 2003 ;Copyright JIJI Press America, Ltd. May 6, 2003 ;Copyright JIJI Press America, Ltd. Sep 22, 2003 ;Copyright JIJI Press America, Ltd. Dec 12, 2003 ;Copyright JIJI Press America, Ltd. Dec 25, 2003 ;Copyright JIJI Press America, Ltd. Nov 20, 2003 ;Copyright JIJI Press America, Ltd. Oct 28, 2003 ;Copyright JIJI Press America, Ltd. Aug 20, 2003 ;Copyright JIJI Press America, Ltd. Aug 12, 2003 ;Copyright JIJI Press America, Ltd. Aug 5, 2003 ;Copyright JIJI Press America, Ltd. Jul 9, 2003 ;Copyright JIJI Press America, Ltd. Jun 19, 2003 ;Copyright JIJI Press America, Ltd. Jun 11, 2003 ;Copyright JIJI Press America, Ltd. May 27, 2003 ;Copyright JIJI Press America, Ltd. Apr 28, 2003 ;Copyright JIJI Press America, Ltd. Apr 21, 2003 ;Copyright JIJI Press America, Ltd. Mar 4, 2003 ;Copyright JIJI Press America, Ltd. Aug 28, 2003 ;Copyright JIJI Press America, Ltd. Apr 14, 2003 ;Copyright JIJI Press America, Ltd. Feb 25, 2003 ;Copyright JIJI Press America, Ltd. Mar 10, 2003 ;Copyright JIJI Press America, Ltd. Jun 4, 2003 ;Copyright JIJI Press America, Ltd. Jul 17, 2003

Digital Resources/Online E-Resources

7
Treatment and vaccines for severe acute respiratory syndrome
Material Type:
Article
Add to My Research

Treatment and vaccines for severe acute respiratory syndrome

The Lancet infectious diseases, 2005-03, Vol.5 (3), p.147-155 [Peer Reviewed Journal]

2005 Elsevier Ltd ;2005 INIST-CNRS ;Copyright Elsevier Limited Mar 2005 ;Copyright © 2005 Elsevier Ltd. All rights reserved. 2005 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(05)01307-1 ;PMID: 15766649 ;CODEN: LANCAO

Full text available

8
JIJI PRESS ROUNDUP OF RECENT BIO NEWS 1
Material Type:
Newsletter Article
Add to My Research

JIJI PRESS ROUNDUP OF RECENT BIO NEWS 1

Jiji Press English News Service, 2005, p.1

Copyright JIJI Press America, Ltd. Jul 1, 2005 ;Copyright JIJI Press America, Ltd. Jun 16, 2005 ;Copyright JIJI Press America, Ltd. Apr 21, 2005 ;Copyright JIJI Press America, Ltd. Dec 30, 2005 ;Copyright JIJI Press America, Ltd. Mar 25, 2005 ;Copyright JIJI Press America, Ltd. Jan 12, 2005 ;Copyright JIJI Press America, Ltd. Dec 16, 2005 ;Copyright JIJI Press America, Ltd. Sep 17, 2005 ;Copyright JIJI Press America, Ltd. Apr 8, 2005 ;Copyright JIJI Press America, Ltd. Oct 7, 2005 ;Copyright JIJI Press America, Ltd. Mar 9, 2005 ;Copyright JIJI Press America, Ltd. May 18, 2005 ;Copyright JIJI Press America, Ltd. Jun 1, 2005 ;Copyright JIJI Press America, Ltd. Aug 8, 2005 ;Copyright JIJI Press America, Ltd. Aug 30, 2005 ;Copyright JIJI Press America, Ltd. Nov 25, 2005 ;Copyright JIJI Press America, Ltd. Oct 28, 2005 ;Copyright JIJI Press America, Ltd. Jan 26, 2005 ;Copyright JIJI Press America, Ltd. Jul 19, 2005

Digital Resources/Online E-Resources

9
Structure and inhibition of the SARS coronavirus envelope protein ion channel
Material Type:
Article
Add to My Research

Structure and inhibition of the SARS coronavirus envelope protein ion channel

PLoS pathogens, 2009-07, Vol.5 (7), p.e1000511-e1000511 [Peer Reviewed Journal]

COPYRIGHT 2009 Public Library of Science ;Pervushin et al. 2009 ;2009 Pervushin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Pervushin K, Tan E, Parthasarathy K, Lin X, Jiang FL, et al. (2009) Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel. PLoS Pathog 5(7): e1000511. doi:10.1371/journal.ppat.1000511 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1000511 ;PMID: 19593379

Full text available

10
Drug combo helps reduce MERS disease in animal study; possible human option
Material Type:
Newsletter Article
Add to My Research

Drug combo helps reduce MERS disease in animal study; possible human option

The Canadian Press, 2013

2013 The Canadian Press. All rights reserved.

Digital Resources/Online E-Resources

11
Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children
Material Type:
Article
Add to My Research

Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children

PloS one, 2014-02, Vol.9 (2), p.e86448-e86448 [Peer Reviewed Journal]

COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014 Nunes et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Nunes et al 2014 Nunes et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0086448 ;PMID: 24498274

Full text available

12
BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection: Broad Spectrum Activity Shown Against Multiple RNA Virus Biothreats
Material Type:
Newsletter Article
Add to My Research

BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection: Broad Spectrum Activity Shown Against Multiple RNA Virus Biothreats

NASDAQ OMX's News Release Distribution Channel, 2014

Copyright NASDAQ OMX Corporate Solutions, Inc. Mar 3, 2014

Digital Resources/Online E-Resources

13
Press Release: BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection
Material Type:
Newsletter Article
Add to My Research

Press Release: BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection

Dow Jones Institutional News, 2014

Copyright Dow Jones & Company Inc Mar 3, 2014

Digital Resources/Online E-Resources

14
Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials
Material Type:
Article
Add to My Research

Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials

Journal of diabetes research, 2015-01, Vol.2015, p.606031-14 [Peer Reviewed Journal]

Copyright © 2015 Jixin Zhong et al. ;Copyright © 2015 Jixin Zhong et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2015 Jixin Zhong et al. 2015 ;ISSN: 2314-6745 ;EISSN: 2314-6753 ;DOI: 10.1155/2015/606031 ;PMID: 26075284

Full text available

15
Mundipharma Presents Research on Efficacy of BETADINE(R) Formulations Against MERS at Inaugural International Meeting on Respiratory Pathogens (IMRP)
Material Type:
Newsletter Article
Add to My Research

Mundipharma Presents Research on Efficacy of BETADINE(R) Formulations Against MERS at Inaugural International Meeting on Respiratory Pathogens (IMRP)

PR Newswire Asia, 2015

Copyright © 2015 PR Newswire Association LLC. All Rights Reserved.

Digital Resources/Online E-Resources

16
Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE(R) in Disease Prevention, Infection Control and Oral Mucositis Treatment: New in-vitro studies demonstrate BETADINE® medicines containing Povidone-Iodine (PVP-I) have a rapid virucidal kill rate against MERS coronavirus
Material Type:
Newsletter Article
Add to My Research

Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE(R) in Disease Prevention, Infection Control and Oral Mucositis Treatment: New in-vitro studies demonstrate BETADINE® medicines containing Povidone-Iodine (PVP-I) have a rapid virucidal kill rate against MERS coronavirus

PR Newswire Asia, 2016

Copyright © 2016 PR Newswire Association LLC. All Rights Reserved.

Digital Resources/Online E-Resources

17
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
Material Type:
Article
Add to My Research

Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2017-05, Vol.372 (1721), p.20160294-20160294 [Peer Reviewed Journal]

2017 The Authors. ;Copyright The Royal Society Publishing May 26, 2017 ;2017 The Authors. 2017 ;ISSN: 0962-8436 ;EISSN: 1471-2970 ;DOI: 10.1098/rstb.2016.0294 ;PMID: 28396467

Full text available

18
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Material Type:
Article
Add to My Research

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

Vaccine, 2017-06, Vol.35 (30), p.3780-3788 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017. Published by Elsevier Ltd. ;Copyright Elsevier Limited Jun 27, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.05.032 ;PMID: 28579232

Full text available

19
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
Material Type:
Article
Add to My Research

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology

Vaccine, 2017-08, Vol.35 (35), p.4461-4464 [Peer Reviewed Journal]

The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.04.085 ;PMID: 28576573

Full text available

20
MERS Antibodies Produced in Cattle Safe, Treatment Well Tolerated in Phase 1 Trial
Material Type:
Newsletter Article
Add to My Research

MERS Antibodies Produced in Cattle Safe, Treatment Well Tolerated in Phase 1 Trial

Targeted News Service, 2018

Copyright © Targeted News Service. All Rights Reserved.

Digital Resources/Online E-Resources

Results 1 - 20 of 11,861  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2009  (9)
  2. 2009 To 2014  (5)
  3. 2015 To 2017  (6)
  4. 2018 To 2021  (9,481)
  5. After 2021  (2,363)
  6. More options open sub menu

Resource Type 

  1. Newsletter Articles  (7,788)
  2. Articles  (1,939)
  3. Newspaper Articles  (1,595)
  4. Web Resources  (264)
  5. magazinearticle  (199)
  6. Text Resources  (45)
  7. Reports  (30)
  8. Audio  (1)
  9. More options open sub menu

Language 

  1. English  (11,857)
  2. Japanese  (86)
  3. Urdu  (16)
  4. Portuguese  (4)
  5. Spanish  (4)
  6. Norwegian  (2)
  7. Italian  (1)
  8. French  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait